Budesonide Capsule, Coated Pellets
Product Images NDC 0904-7313

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0904-7313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Budesonide (08f8aa4f 4543 46d3 91f7 Ae943f455648 01)

Budesonide (08f8aa4f 4543 46d3 91f7 Ae943f455648 01)
Chemical structure diagram showing the two epimers (22R and 22S) of budesonide, a corticosteroid medication. The structures depict the steroid framework and specific functional groups characteristic of budesonide.*
FDA Label Image

3mg Carton Label (08f8aa4f 4543 46d3 91f7 Ae943f455648 00)

3mg Carton Label (08f8aa4f 4543 46d3 91f7 Ae943f455648 00)
Label for Major Pharmaceuticals Budesonide Delayed-Release capsules, 3 mg strength. The label identifies the product as oral capsules with enteric coating, available in a 20-capsule unit dose package (2 x 10). It includes dosage instructions, storage conditions, and a warning that the unit dose package is for institutional use only and not child resistant. The label also shows the NDC 0904-7313-10 and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.